The global equine health market is likely to derive growth from an increasing number of product launches aimed at enhancing equine health.
A black and white horse communicating nose to nose with a bay horse
The global equine health market is likely to grow with an increasing number of product launches aimed at enhancing equine health.
© 2010 by Jimmie New window.
According to a report by Fortune Business Insights, titled “Equine Health Market Size, Share and Industry Analysis the market will grow by product type including drugs, vaccines, and feed additives, by disease type such as Nile virus, Potomac horse fever, equine rabies, tetanus, equine influenza, by distribution channels including veterinary hospitals and clinics, retail pharmacies, online pharmacies and regional forecast. During 2019-2026, the market will need to respond to the increasing prevalence of infectious animal diseases.
Horses are involved in various kinds of activities such as racing, polo, agriculture transport, warfare, entertainment, and therapeutic uses. Equines are also one of the most widely adopted pets in the world. These factors have created an emphasis on equine health in recent years. As a result, there has been an increase in the overall investment aimed at the betterment of equine health.
Highlights of the Report:
- In-depth analysis of various insights, namely, Equine Health Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Equine Health Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
Key Players Operating in The Equine Health Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Boehringer Ingelheim International GmbH
- Bayer AG
- Elanco, Intervet Inc.
- Purina Animal Nutrition LLC
- Equine Products UK LTD
- Zoetis
- Vetoquinol S.A.
High Prevalence of Equine Diseases to Boost the Market in North America
Besides the factors mentioned above, the report classifies the market on the basis of regional demographics. The report categorizes the global equine health market into five main regions that are North America, Latin America, the Middle East and Africa, Asia Pacific, and Europe. Among these regions, the rate of adoption of an equine as a pet is the highest in North America. Moreover, there is a high prevalence of infectious diseases in this region. Along with the aforementioned factors, the availability of excellent treatment options will aid the growth of the equine health market in North America. Increased healthcare expenditure is another factor that has contributed to market growth.
Press release from Fortune Business Insights